Tandem Diabetes Care (TNDM) Fundamental Analysis: Revenue, Earnings & Valuation

0.23 / 10

Underperform

Fundamental analysis rates TNDM as Underperform with a low 0.2/10 score. Asset‑MV and Profit‑MV are modestly positive, while Cash‑MV, ROA and profit margins are negative, indicating weak financial health.

Analysis Checks(4/10)

Revenue-MV

Value0.39

Score1/3

Weight23.39%

1M Return-0.97%

ROA (%)

Value-22.15

Score0/3

Weight101.66%

1M Return-6.58%

Net cash flow from operating activities / Operating revenue (%)

Value-0.96

Score2/3

Weight-40.26%

1M Return1.48%

Profit-MV

Value0.66

Score2/3

Weight-86.92%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-22.15

Score0/3

Weight101.66%

1M Return-6.58%

EBIT / Total operating revenue (%)

Value-18.96

Score1/3

Weight17.10%

1M Return-0.83%

Asset-MV

Value-0.55

Score3/3

Weight-132.02%

1M Return4.62%

Net profit / Total operating revenue (%)

Value-20.17

Score1/3

Weight19.53%

1M Return-0.84%

Cash-MV

Value-1.55

Score1/3

Weight82.39%

1M Return-4.16%

Net profit / Total profit (%)

Value102.22

Score2/3

Weight13.47%

1M Return-0.54%

Is TNDM fundamentally strong?

TNDM scores 0.23/10 on fundamentals and holds a Premium valuation at present. Backed by its -97.88% ROE, -20.17% net margin, -7.01 P/E ratio, 9.25 P/B ratio, and -106.80% earnings growth, these metrics solidify its Underperform investment rating.